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        Introduction 
  The profound roles that TGF      plays during embryogenesis, 
adult tissue homeostasis, and disease pathogenesis necessitate 
deeper understanding of mechanisms that regulate this signal-
ing pathway. Signaling occurs via the TGF      type II receptor 
(T    RII)  that  trans-phosphorylates  T    RI, also known as activin 
receptor-like kinase (ALK) 5. Activated ALK5 phosphorylates 
receptor-regulated Smads (Smad2 and Smad3), promotes their 
association with Smad4, and leads to regulation of transcription 
(  Feng and Derynck, 2005  ). 
  Smad7, a negative regulator of TGF     /Smad signaling, is 
an immediate early gene target of the pathway (for review see 
  Itoh and ten Dijke, 2007  ). Smad7 binds to ALK5, competing 
with Smad2/3 phosphorylation and mediating receptor ubiqui-
tination, mechanisms which link to the process of TGF      recep-
tor internalization and lysosomal degradation (  Di Guglielmo 
et al., 2003  ). 
  We have identified gene targets of Smad signaling 
(  Kowanetz et al., 2004  ). A highly regulated gene,   SNF1LK  
(  sucrose nonfermented 1-like kinase  ) or   salt-inducible kinase 1  
(  SIK1  , hereby abbreviated as SIK), encodes a serine/threonine 
kinase. SIK is one of 14 AMP-activated protein kinases that can 
be phosphorylated by the tumor suppressor LKB1 (  Alessi et al., 
2006  ). SIK expression is induced during cardiogenesis and 
skeletal muscle differentiation (  Ruiz et al., 1994  ) or in adrenal 
glands, leading to steroidogenesis (  Okamoto et al., 2004  ). 
  We uncover a new functional role of SIK in the TGF     
pathway. SIK induction is necessary for physiological TGF     
signaling. Ubiquitin promotes association of SIK to Smad7, 
which down-regulates ALK5. Thus, SIK defi  nes a new negative-
feedback loop initiated by incoming Smad signals. 
  Results and discussion 
  TGF     induces SIK in a 
Smad-dependent manner 
  We have reported Smad4-dependant gene profi  les in response 
to TGF   1 or bone morphogenetic protein (BMP) 7 using human 
  S
ignal transduction by transforming growth factor       
(TGF     ) coordinates physiological responses in di-
verse cell types. TGF      signals via type I and type II 
receptor serine/threonine kinases and intracellular Smad 
proteins that regulate transcription. Strength and duration 
of TGF      signaling is largely dependent on a negative-
feedback program initiated during signal progression. We 
have identiﬁ  ed an inducible gene target of TGF     /Smad 
signaling, the salt-inducible kinase (SIK), which negatively 
regulates signaling together with Smad7. SIK and Smad7 
form a complex and cooperate to down-regulate the acti-
vated type I receptor ALK5. We further show that both the 
kinase and ubiquitin-associated domain of SIK are re-
quired for proper ALK5 degradation, with ubiquitin func-
tioning to enhance SIK-mediated receptor degradation. 
Loss of endogenous SIK results in enhanced gene responses 
of the ﬁ  brotic and cytostatic programs of TGF     . We thus 
identify in SIK a negative regulator that controls TGF      re-
ceptor turnover and physiological signaling.
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  Caenorhabditis elegans   orthologue of SIK, Kin-29, regulates 
chemosensory neuronal signaling and body size, a process 
which is dependent on TGF     /Smad (  Lanjuin and Sengupta, 2002  ; 
  Maduzia et al., 2005  ), which is in agreement with our data. 
  SIK down-regulates activated ALK5 
  Gain-of-function experiments with transfected SIK showed 
specifi  c down-regulation of ALK5 after TGF    1  stimulation, 
whereas minor effects were scored without stimulation (  Fig. 2 A  ). 
[ID]FIG2[/ID]  
SIK did not down-regulate Smad7 or GFP (Fig. S1 B), ex-
cluding translational inhibition or induction of proteolysis. 
  SIK affected ALK5 turnover as it reduced the half-life of 
a constitutively active (CA) ALK5 from 5.5 to 2.8 h without 
affecting a KR- (kinase-dead) ALK5 or an unrelated adaptor 
protein CIN85 (  Fig. 2 B  ). Proteasomal (LLnL) and lysosomal 
(chloroquine) inhibitors stabilized the ALK5 levels in the pres-
ence of SIK (  Fig. 2 C  ), suggesting both proteasomal and lyso-
somal mechanisms in ALK5 down-regulation by SIK. 
  SIK has an N-terminal kinase domain with lysine 56 bind-
ing to ATP and a central ubiquitin-associated (UBA) domain, 
which regulates conformation and kinase activity (  Jaleel et al., 
2006  ). A catalytically inactive (K56R) SIK or a deletion mutant 
lacking the UBA domain (     UBA) failed to down-regulate CA-
ALK5 (  Fig. 2 D  ). This suggests that both catalytic activity and 
UBA domain of SIK affect ALK5 turnover. 
  RNAi against SIK signifi   cantly enhanced endogenous 
ALK5 levels (  Fig. 2 E  ). Increased presence of endogenous cell 
surface receptors measured with chemically cross-linked radio-
ligand upon depletion of SIK further strengthened this evidence 
(  Fig. 2 F  , 0 h). Thus, endogenous SIK must regulate total ALK5 
levels, which also affects cell surface receptor numbers, avail-
able for signaling. Receptor down-regulation was also slower 
after SIK RNAi. Signifi  cantly higher ligand-bound receptor 
levels were observed for up to 1 h of internalization compared 
with control (  Fig. 2 F  ). 
  Because proteasomal and lysosomal inhibitors block 
ALK5 degradation (  Fig. 2 C  ), we suggest that ALK5 turnover 
takes place in lysosomes. Proteasomes might promote traffi  ck-
ing to the lysosome, as has already been established for the EGF 
receptor (  Longva et al., 2002  ;   Alwan et al., 2003  ). How protea-
somes regulate TGF-      receptor internalization and degradation 
remains unclear. 
  SIK associates and cooperates 
with Smad7 for ALK5 down-regulation 
  Down-regulation of ALK5 is mediated by Smad7 (for review 
see   Itoh and ten Dijke, 2007  ). We reasoned that SIK could asso-
ciate directly with ALK5 or Smad7. Coimmunoprecipitation 
assays showed that SIK formed complexes with both ALK5 and 
Smad7 (  Fig. 3, A and B  ). 
[ID]FIG3[/ID]  To detect SIK  –  ALK5 complexes, we 
had to achieve low SIK expression and high CA-ALK5 levels, 
which resulted in active ALK5 signaling with small effects on 
receptor down-regulation. SIK bound stronger to the Smad7 
linker and C-terminal (Mad homology 2) domains than to its 
N-terminal domain (  Fig. 3 B  ). When endogenous human ALK5, 
Smad7, and SIK were immunoprecipitated from HaCaT lysates, 
SIK coprecipitated primarily with Smad7 and weakly with 
breast carcinoma MDA-MB-468 cells that lack both   Smad4  
gene copies (  Kowanetz et al., 2004  ). After reconstitution with 
Smad4, TGF   1 or BMP7 rapidly induced  SIK  mRNA, followed 
by slow decrease (  Fig. 1, A and B  ). 
[ID]FIG1[/ID]  In human HaCaT keratino-
cytes, TGF     1 induced and sustained   SIK   mRNA and protein lev-
els (  Fig. 1, C and D  ; and Fig. S1 A, available at http://www.jcb
.org/cgi/content/full/jcb.200804107/DC1). Endogenous TGF    1-
induced SIK protein showed punctate nuclear, cytoplasmic, 
and peripheral localization (  Fig. 1 E  ).   SIK   represents a new 
gene target of TGF     /BMP7 Smad signaling. Interestingly, the 
  Figure 1.       Smad signaling induces endogenous   SIK  .   (A) cDNA micro-
array analysis of   SIK   mRNA in Smad4-deﬁ  cient MDA-MB-468 cells after 
infection with adenovirus expressing LacZ or Smad4 and stimulation with 
2 ng/ml TGF     1 or 300 ng/ml BMP7. Normalized mean expression 
values with error bars from triplicate microarray expressions are shown 
(arbitrary units). (B and C) Semiquantitative RT-PCR analysis of   SIK   and 
  GAPDH   mRNA in MDA-MB-468 cells as in A (B) or in response to 2 ng/ml 
TGF     1 in HaCaT cells (C). Ampliﬁ  ed cDNA sizes are in bp. (D) SIK and 
     -tubulin loading control protein proﬁ  les in response to 5 ng/ml TGF     1 
in HaCaT cells. Protein sizes are in kilodaltons. (E) Induction of nuclear 
and cytoplasmic levels of endogenous SIK by 5 ng/ml TGF     1 in HaCaT 
cells (bar, 10   μ  m).     657 SIK NEGATIVELY REGULATES TGF      SIGNALING   • Kowanetz et al. 
clusters (  Fig. 3 D  , insets). Thus, SIK, Smad7, and ALK5 
must form complexes in cytoplasmic regions proximal to the 
plasma membrane. 
  To verify the cooperation of Smad7 and SIK in negatively 
regulating TGF      signaling, we measured the effects of SIK 
and Smad7 on the transcriptional induction of a Smad3/Smad4-
specifi  c promoter-reporter, CAGA  12 ,  by TGF    1 (  Fig. 3 E  ). SIK 
enhanced the inhibitory effect of Smad7 by more than twofold. 
Knockdown of endogenous Smad7 stabilized and rescued CA-
ALK5 down-regulation by SIK, even though Smad7 depletion 
led to increased SIK levels (  Fig. 3 F  ). Thus, SIK mediates 
down-regulation of signaling ALK5 receptor in a Smad7-
dependent manner. 
ALK5 (  Fig. 3 C  ), confi  rming the evidence with transfected pro-
teins. Thus, protein complexes between endogenous SIK, Smad7, 
and ALK5 occur in vivo. 
  Smad7 resides in the nucleus and moves to the cyto-
plasm in response to TGF-      (for review see   Itoh and ten Dijke, 
2007  ). SIK also resides in both nucleus and cytoplasm, and its 
localization is regulated by hormones in adrenal cells or by 
the 14  –  3-3 adaptor (  Okamoto et al., 2004  ;   Al-Hakim et al., 
2005 ).  In  transfected  TGF    -sensitive Mv1Lu cells, SIK local-
ized in nuclei and cytoplasm with pronounced punctate distri-
bution proximal to the plasma membrane (  Fig. 3 D  ), which is 
similar to endogenous SIK (  Fig. 1 E  ). Colocalization of SIK, 
CA-ALK5, and Smad7 was primarily observed in peripheral 
  Figure 2.       SIK down-regulates activated ALK5.   
(A) Immunoblot of ALK5 expressed in COS1 
cells together with T     RII and stimulation or not 
with 2 ng/ml TGF-     1 for 12 h in the absence 
or presence of increasing wild-type GFP-SIK 
amounts. (B and C) Pulse-chase analysis of 
CA-ALK5, KR-ALK5, and CIN85 in the absence 
( ) or presence (+) of cotransfected SIK (S). 
A 30-min pulse was followed by chase for the 
indicated times. Treatment with proteasomal 
(LLnL 200   μ  M; S + L) or lysosomal (chloroquine 
400   μ  M; S + Q) inhibitor during the chase is 
shown in C. Radioactive quantitation of ALK5 
or CIN85 protein is plotted relative to the 
pulse signal. Representative data from three 
independent repeats are shown. Protein auto-
radiograms are shown below each graph. 
(D) Immunoblot of CA-ALK5 in COS1 cells co-
transfected with wild-type and mutant SIK con-
structs. (E, top) quantitative real-time RT-PCR 
analysis of   SIK   mRNA in HaCaT cells after trans-
fection with control (siLuc) and speciﬁ  c (siSIK) 
siRNAs and 8 h of stimulation with 5 ng/ml 
TGF     1. Mean fold induction of TGF     -stimulated 
  SIK   (black bars) relative to unstimulated levels 
(gray bars) are plotted, with standard errors 
determined from triplicate samples. (E, bottom) 
Immunoblot of endogenous SIK, ALK5, and 
     -tubulin loading control in HaCaT total cell 
lysates (TCL) prepared as per mRNA analysis. 
(F) Mv1Lu cells transfected with control (siLuc) 
or speciﬁ  c (siSIK) siRNA were incubated with 
radio-TGF     1 before cross-linking and incuba-
tion at 37  °  C for the indicated time periods. 
Cell surface receptor autoradiograms show the 
three TGF-      receptors (T     R) marked as type I, 
II, and III, and the unbound ligand (TGF     ) mi-
grating at the bottom. Protein sizes are in kilo-
daltons. Black lines indicate that intervening 
lanes have been spliced out.     JCB • VOLUME 182 • NUMBER 4 • 2008  658
(  Fig. 4 C   and Fig. S2 A, available at http://www.jcb.org/cgi/
content/full/jcb.200804107/DC1). SIK readily coprecipitated ubiq-
ui  tinated proteins of diverse sizes, confi  rming that they were dis-
tinct from ubiquitinated SIK. Wild-type and SIK-K56R bound to 
ubiquitinated proteins, whereas SIK-     UBA or a mutant lacking 
both kinase and UBA domains (     N) did not, suggesting that the 
SIK UBA domain is needed for binding to polyubiquitinated pro-
teins (  Fig. 4 C  ). C-terminal deletion of SIK, after its UBA do-
main, had no effect on binding ubiquitinated proteins (  Fig. 4 C  ). 
Thus, SIK can associate with ubiquitinated proteins in cells. 
 Obvious ubiquitinated protein candidates to which SIK could 
bind were ALK5 and Smad7. Accordingly, the SIK  – Smad7  com-
plex was enhanced by coexpressing ubiquitin, whereas deletion of 
the UBA domain of SIK prohibited such enhancement (  Fig. 4 D  ). 
A slow migrating SIK form was obvious in complex with Smad7 
( Fig. 4 D , asterisk), which may represent ubiquitinated SIK. In con-
trast, neither ubiquitin nor UBA domain deletion had any ef-
fect on SIK  –  ALK5 complexes (Fig. S2 B). Ubiquitin therefore 
enhances association between SIK and Smad7, and the SIK 
UBA domain mediates formation of this ternary complex. 
  The SIK UBA domain was recently shown to not bind ubiq-
uitin but to modulate SIK kinase activity in vitro ( Jaleel et al., 2006 ). 
  Ubiquitin and the UBA domain modulate 
ALK5 regulation by SIK 
  We examined whether ubiquitin affected the ability of SIK to 
facilitate ALK5 degradation (  Fig. 4 A  ). 
[ID]FIG4[/ID]  Ubiquitin signifi  -
cantly enhanced the potency of CA-ALK5 down-regulation 
by SIK. A K48R ubiquitin mutant completely blocked this 
down-regulation. This implies that polyubiquitin chain forma-
tion via lysine 48 affects ALK5 degradation, which is compati-
ble with a proteasome-dependent mechanism and inhibition of 
ALK5 degradation by LLnL (  Fig. 2 D  ). 
  We examined SIK localization in relation to ubiquitin in 
Mv1Lu cells (  Fig. 4 B  ). SIK distributed in nuclei, cytoplasm, 
and prominent peripheral structures, SIK-K56R showed more 
cytoplasmic enrichment, and both colocalized with cytoplasmic 
ubiquitin clusters. SIK lacking its UBA domain showed no co-
localization, as it distributed diffusely in the cytoplasm, sug-
gesting that SIK-ubiquitin clusters depend on the integrity of 
the UBA domain. These punctate structures were also enriched 
in 19S and 20S proteasomes (unpublished data). 
  We then expressed SIK and ubiquitin in different pools of 
cells before immunoprecipitation to measure association of SIK 
with ubiquitinated proteins but not SIK ubiquitination, per se 
  Figure 3.       SIK associates and cooperates with 
Smad7 to down-regulate ALK5.   (A) Coimmuno-
precipitation of CA-ALK5 with wild-type (WT) 
SIK and TCL controls for SIK. Low levels of SIK 
coexpressed with high levels of CA-ALK5 al-
lowed detection of SIK  –  ALK5 complexes with 
only small effects on receptor down-regulation. 
(B) Coimmunoprecipitation of wild-type SIK 
with wild type and various Smad7 domains 
(C, C-terminal; Link, linker; N, N-terminal). TCL 
controls for SIK and immunoglobulin chains 
(Ig) are shown. (C) Coimmunoprecipitation 
of endogenous SIK with endogenous ALK5 
and Smad7. HaCaT cell lysates, pretreated 
with 50   μ  M MG132 and 5 ng/ml TGF     1 
overnight, were immunoprecipitated with 
anti-ALK5, anti-Smad7, and anti-SIK (988) 
antibodies, followed by immunoblotting with 
anti-SIK (988) antibody. TCL immunoblots with 
the three antibodies demonstrate speciﬁ  city 
of each antiserum. Asterisks indicate speciﬁ  c 
protein bands and sizes are in kilodaltons. 
The top left panel (Mock and ALK5) was ex-
posed four times longer than the top right 
panel (Smad7 and SIK). (D) Triple confocal 
immunoﬂ  uorescence analysis of wild-type SIK, 
CA-ALK5, and wild-type Smad7 in transfected 
Mv1Lu cells. Insets show high magniﬁ  cations 
of peripheral clusters just below the plasma 
membrane (bar, 10   μ  m). (E) SIK represses syn-
ergistically with Smad7 CAGA  12   promoter in-
duction by 0.5 ng/ml TGF     1 for 6 h in HepG2 
cells transfected with empty vector or Flag-SIK 
and Flag-Smad7. Normalized promoter activ-
ity is plotted as mean values from triplicate 
determinations with standard error bars. (F) De-
pletion of endogenous Smad7 stabilizes the 
CA-ALK5 receptor and wild-type SIK. Immuno-
blot of HEK293T cell extracts after transient 
transfection with shRNA vector pSuper-Smad7 
or its empty (mock) version together with in-
creasing amounts (triangles) of GFP-SIK and 
constant amount of CA-ALK5. The asterisks in-
dicate nonspeciﬁ  c protein bands. Protein sizes 
are shown in kilodaltons.     659 SIK NEGATIVELY REGULATES TGF      SIGNALING   • Kowanetz et al. 
how TGF     receptor signaling is negatively regulated (  Fig. 5 F  ). 
SIK joins Smad7 in the negative-feedback loop of TGF      sig-
naling (for review see   Itoh and ten Dijke, 2007  ). SIK and 
Smad7 interact, and ubiquitin enhances their complex. SIK 
also binds to ALK5 and down-regulates the receptor in a 
Smad7-dependent manner. This model applies to various epi-
thelial cell models that are highly sensitive to TGF      including 
keratinocytes and lung cells. Our study emphasizes the role of 
ubiquitin and proteasomes in regulation of TGF      signaling  by 
SIK. Our data also support a role for the kinase activity of SIK 
(  Fig. 2 D  ). This offers the fi  rst evidence for a kinase/ubiquitin 
binding protein being involved in the down-regulation of a 
signaling receptor. Identifying possible SIK substrates within 
the ALK5  –  Smad7 complex and explaining their functional 
role in regulation of TGF      signaling will be important. We pro-
vide evidence for lysosomal degradation of TGF      receptors 
( Fig.  2  C ).  This  is  a  relatively unexplored step during TGF     
receptor internalization. TGF      receptor ubiquitination and 
proteasomal degradation is often reported (for review see   Itoh 
and ten Dijke, 2007  ). A lysosomal pathway of receptor-ligand 
degradation would better fit to the classical mechanisms of 
receptor internalization and degradation. During this process, 
ubiquitin and proteasomes might act as intermediate proces-
sors of TGF      receptor traffi  cking from the plasma membrane 
to the lysosome. 
  Evolutionary conservation of SIK from humans to   C. ele-
gans  , and functional conservation of SIK as a regulator of ho-
meostatic (this study) and developmental (  Maduzia et al., 2005  ) 
We also failed in demonstrating in vitro binding of recombinant 
mono- or oligoubiquitin chains to SIK (unpublished data). SIK 
immunopurifi  ed from mammalian cells clearly bound to ubiqui-
tinated proteins via its UBA domain (  Fig. 4 C   and Fig. S2 A). This 
could refl  ect an in vivo modifi  cation or the requirement for another 
binding protein. Further studies will reveal the mechanism by which 
ubiquitin and the SIK UBA domain regulate its own function. 
  SIK negatively regulates TGF     signaling 
  Stimulation of cells after endogenous SIK depletion enhanced the 
potency of TGF-      signaling (  Fig. 5, A and B  ). 
[ID]FIG5[/ID]  Signaling was 
assessed by measuring mRNA levels of well characterized TGF     
gene targets, representing three distinct physiological programs: 
the fi  brotic program (  plasminogen activator inhibitor 1   [ PAI-1 ], 
TGF      inducible), the cytostatic program (cell cycle inhibitors 
  p21   and   p15 ,  TGF     inducible; transcriptional regulators   c-myc  
and   Id2 ,  TGF     repressible), and the negative-feedback program 
(  Smad7 ,  TGF    -inducible;   Fig. 5 B   and Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200804107/DC1). We also 
confi  rmed that SIK knockdown enhanced the magnitude of endog-
enous PAI-1 and p21 protein accumulation in response to TGF    1 
(  Fig. 5 C  ). Finally, protein levels and pericellular localization of 
fi  bronectin, another TGF      gene target from the fi  brotic program, 
augmented signifi  cantly after depleting SIK (  Fig. 5, D and E  ). 
Thus, induction of SIK by TGF      represents a central step in 
negative regulation of TGF      signaling. 
 The  identifi  cation of   SIK   as an immediate early gene in-
duced by the Smad pathway led to important new insights into 
  Figure 4.       Role of ubiquitin and the UBA domain 
of SIK in ALK5 down-regulation.   (A) Immuno  -
blot of CA-ALK5 in the presence of increasing 
doses of WT GFP-SIK and co  expression of WT 
or K48R mutant ubiquitin. (B) Confocal immuno-
ﬂ   uorescence analysis of wild-type or mutant 
SIK proteins cotransfected with HA-ubiquitin 
in Mv1Lu cells. Insets show higher magniﬁ  ca-
tions of peripheral clusters below the plasma 
membrane (bar, 10   μ  m). (C) SIK lysate was 
mixed brieﬂ  y with lysate for ubiquitinated pro-
teins before immunoprecipitation. SIK mutant 
proteins were immunoprecipitated (anti-Flag) 
and ubiquitinated proteins are detected (anti-
HA immunoblot). Total SIK levels (bottom) and 
immunoglobulin heavy chain (Ig) are shown. 
(D) Coimmunoprecipitation of wild-type Smad7 
with wild-type myc-SIK or UBA deletion mutant 
in the absence or presence of ubiquitin. The as-
terisk indicates a slow migrating SIK species, 
possibly representing ubiquitinated SIK. TCL 
controls of SIK variants, the immunoglobulin 
heavy chain (Ig), and protein sizes in kilodal-
tons are shown. Black lines indicate that inter-
vening lanes have been spliced out.     JCB • VOLUME 182 • NUMBER 4 • 2008  660
in processes of TGF      signaling and receptor down-regulation. 
Thus, SIK being a component of the T    R – Smad7  complex  pro-
vides a nodal point for crosstalk of the TGF      pathway with LKB1 
or AMP-activated protein kinase pathways. SIK therefore opens 
a new window for the elucidation of the process of down-
regulation of serine/threonine kinase receptors. 
pathways guided by TGF      signaling opens new territories for 
exploration of such pathways across species. Characterizing the 
role of the   Drosophila melanogaster   SIK orthologue will greatly 
benefi  t this cause. 
  Because SIK is activated by the tumor suppressor kinase 
LKB1 (  Alessi et al., 2006  ), our study suggests a role of LKB1 
  Figure 5.       Endogenous SIK negatively regu-
lates endogenous TGF     signaling.   (A) Immuno-
blot of endogenous SIK and      -tubulin loading 
control in HaCaT TCL after transfection with 
control (siLuc) and speciﬁ   c (siSIK) siRNAs 
and 12 h of stimulation with 5 ng/ml TGF     1. 
The asterisk marks a nonspeciﬁ  c protein band. 
(B) Quantitative real-time RT-PCR analysis in 
HaCaT cells treated with siRNAs as in A and 
stimulated with 5 ng/ml TGF     1 for 6 h (  PAI-1   and 
  p21  ) or 8 h (  Smad7   and   p15  ). Mean fold in-
duction of TGF     -stimulated mRNA levels (black 
bars) relative to unstimulated levels (gray bars) 
are plotted, with standard errors determined 
from triplicate or quadruplicate samples. Aster-
isks indicate signiﬁ  cant difference (  t   test: P   <  0.05) 
in mRNA levels in cells transfected with siLuc 
versus siSIK siRNA and stimulated with TGF     1. 
(C) Immunoblot of endogenous PAI-1, p21, and 
     -tubulin loading control in HaCaT cells treated 
as in A and stimulated with 5 ng/ml TGF     1 
for the indicated times. Black lines indicate 
that intervening lanes have been spliced out. 
(D) Immunoﬂ   uorescence analysis of endog-
enous ﬁ  bronectin in HaCaT cells treated as in 
A and stimulated with 5 ng/ml TGF     1 for 12 h 
(bar, 10   μ  m). (E) Immunoblot of endogenous 
ﬁ  bronectin and      -tubulin loading control in the 
same experimental setup as in D. Protein sizes 
are shown in kilodaltons. (F) Model of SIK as 
a negative regulator of TGF      signaling. TGF      
receptors activate nuclear Smad complexes 
with transcription factors (TF) to mediate 
gene responses (green circles). Genes of the 
cytostatic (proliferation), differentiation, ECM, 
and negative-feedback programs are listed. 
Negative-feedback loop protein products as-
semble the machinery that inhibits signaling. 
SIK associates with the T     RI and Smad7, 
promoting internalization and termination of 
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  Vectors pcDNA3-ALK5(wt)-HA (wild-type receptor with C-terminal 
hemagglutinin tag), pcDNA3-ALK5(CA)-HA (CA T204D mutant receptor), 
pcDNA3-ALK5(KR)-HA (kinase dead ATP-binding site mutant receptor), 
pcDNA3-Flag-Smad7, pcDNA3-6myc-Smad7, pcDNA3-6myc-Smad7 
deletion mutants (N-, Linker, C-), pcDNA3-HA-ubiquitin, and pcDNA3-
HA-ubiquitin(K48R) and gene reporters pGL3-CAGA  12  -luc and pCMV-     gal 
were previously described (  Mor  é  n et al., 2005  ); pcDNA3-CIN85 was 
from I. Dikic (Goethe University, Frankfurt, Germany); pcDNA3-T     RI(wt)-
Flag and pcDNA3-T     RII(wt)-Flag were from E.B. Leof (Mayo Clinic, Roch-
ester, MN); pSuper-Smad7 expressing a short hairpin RNA against mouse 
and human Smad7 mRNAs was made by ligating the Smad7-speciﬁ  c hair-
pin (5     -GATCCCC  GAGGCTGTGTTGCTGTGAA  TT CAAGAGA  TTCACAG-
CAACACAGCCTC  TTTTTGGAAA-3     ; underlined sequences show the 
hairpin stem) to pSuper (a gift from R. Agami, Netherlands Cancer Institute, 
Amsterdam, Netherlands;   Brummelkamp et al., 2002  ). 
  Transient transfections 
  HaCaT cells were transfected with siRNAs via Lipofectamine 2000 (Invitro-
gen) or SiLentFect (Bio-Rad Laboratories), COS1 and Mv1Lu cells via Lipo-
fectamine, and HEK293T and HepG2 cells via calcium phosphate as 
previously described (  Kowanetz et al., 2004  ). 24 h after transfection, cells 
were stimulated with TGF-     1 as indicated in the ﬁ  gures. 
  RT-PCR 
  Total HaCaT or MDA-MB-468 RNA was analyzed by quantitative or semi-
quantitative RT-PCR as previously described (  Niimi et al., 2007  ). PCR 
primers are listed in   Tables I and II  , and   glyceraldehyde-3    -phosphate 
dehydrogenase   (  GAPDH  ) was the reference gene. 
[ID]TBL1[/ID]  [ID]TBL2[/ID]  A two-tailed paired Stu-
dent  ’  s   t   test (signiﬁ  cance at P   <   0.05) was used to compare TGF     1-inducible 
  Materials and methods 
  Reagents 
  HaCaT keratinocytes, MDA-MB-468, HEK293T and HepG2 carcinoma, 
COS1 and Mv1Lu cells, and culture conditions were as previously described 
(  Kowanetz et al., 2004  ;   Mor  é  n et al., 2005  ). Recombinant TGF-     1 was 
obtained from PeproTech. Anti  –       -tubulin (T8535) and anti-Flag (M5) anti-
bodies were obtained from Sigma-Aldrich; anti-GFP (A11122) from Invitro-
gen; anti  –  PAI-1 and anti-p21 (Cip1/WAF1) from BD Biosciences; anti-HA 
(Y-11), anti-T     RI (V-22), and anti  –       -tubulin (TU-02) from Santa Cruz Biotech-
nology, Inc.; rabbit polyclonal anti  –  human SIK (988, raised against peptide 
CEEQDTQESLPSSTGRR mapping C-terminally from the UBA domain), anti-
Smad7, and mouse monoclonal anti-myc (9E10) were made in house; rab-
bit polyclonal anti-CIN85(CT) was from I. Dikic (Goethe University, Frankfurt, 
Germany); secondary antibodies coupled to HRP from GE Healthcare; sec-
ondary antibodies coupled to FITC and TRITC from Dako; Alexa Fluor 546 from 
Invitrogen; and AMCA7 (7-amino-4-methylcoumarin-3-acetic acid) from Jackson 
ImmunoResearch Laboratories. 
  Human   SIK  -speciﬁ   c siRNA, ON-TARGET plus SMARTpool reagent 
L-003959-00, and control siRNA against the   luciferase   reporter vector pGL2 
(  X65324  ) were from Thermo Fisher Scientiﬁ  c. An EST clone BG719047 of 
human SIK complete cDNA was obtained from H. Takemori and M. Oka-
moto (National Institute of Biomedical Innovation, Osaka, Japan). The cDNA 
was fused to a Flag, 6myc, and GFP creating pcDNA3-Flag-hSIK, pcDNA3-
6myc-hSIK, and pEGFP-hSIK. The SIK ATP binding site mutant K56R was cre-
ated by the Quick-Change mutagenesis kit (Stratagene). Deletion mutants 
SIK-     UBA, SIK (K56R)-     UBA, SIK-     C, and SIK-     N were created using 
a PCR-based strategy and were subcloned in pcDNA3-Flag and pEGFP. 
DNA constructs were sequence veriﬁ  ed. 
  Table I.       Human oligonucleotide primers used for RT-PCR   
  Gene   Primer Sequence    Strand   Product size    Temperature   PCR cycle    Reference 
  bp   °  C
  SIK 5     -GTCTGGGCGCACCTTTAGCA-3      
  5     -CAGCCTTTCGCCCAGTCTTT-3    
+ 
      
387 62 27   NM_173354 
  IDB2 5     -ACGACCCGATGAGCCTGCTA-3      
  5     -TCCTGGAGCGCTGGTTCTG-3    
+ 
      
213 55 24   Kowanetz et al. (2004  )
  CDKN1A 
(p21) 
5     -CTGCCCAAGCTCTACCTTCC-3      
  5     -CAGGTCCACATGGTCTTCCT-3    
+ 
      
123 57 28   Kowanetz et al. (2004  )
  c-MYC 5     -ACCCGGACGACGAGACCTTCATCA-3      
  5     -GGGGCTGGTGCATTTTCGGTTGTT-3    
+ 
      
683 63 23   Kowanetz et al. (2004  )
  MADH7 
(Smad7) 
5     -CAGATTCCCAACTTCTTCTG-3      
  5     -GTTGAAGATGACCTCCAGCC-3    
+ 
      
533 53 27   Kowanetz et al. (2004  )
  GAPDH 5     -ATCACTGCCACCCAGAAGAC-3      
  5     -ATGAGGTCCACCACCCTGTT-3    
+ 
      
443 57 22   Kowanetz et al. (2004  )
A previously published reference or the NCBI database accession number is indicated.
  Table II.       Human oligonucleotide primers used for quantitative real-time RT-PCR   
  Gene   Primer Sequence    Strand   Product size    Temperature   Reference 
  bp     °  C 
  SIK 5     -CAACCTGGGCGACTACGATGAGCA-3      
  5     -GGGCGCACTGGGCATTCCGATACT-3    
+ 
      
167 60   NM_173354 
  CDKN1B 
(p15) 
5     -TGGACCTGGTGGCTACGAAT-3     (+) 
  5     -AGGGCCTAAGTTGTGGGTTCA-3     (     )
+ 
      
150 60   Niimi et al. (2007  )
  CDKN1A 
(p21) 
5     -CTGCCCAAGCTCTACCTTCC-3     (+) 
  5     -CAGGTCCACATGGTCTTCCT-3     (     )
+ 
      
123 60   Niimi et al. (2007  )
  PAI-1 5     -GAGACAGGCAGCTCGGATTC-3      
  5     -GGCCTCCCAAAGTGCATTAC-3    
+ 
      
101 60 ENST00000223095
  MADH7 
(Smad7) 
5     -ACCCGATGGATTTTCTCAAACC-3      
  5     -GCCAGATAATTCGTTCCCCCT-3    
+ 
      
85 60 ENST00000262158
  GAPDH 5     -GGAGTCAACGGATTTGGTCGTA-3     (+) 
  5     -GGCAACAATATCCACTTTACCAGAGT-3     (     )
+ 
      
78 60   Niimi et al. (2007  )
A previously published reference, the NCBI database accession number, or the Ensembl database transcript (ENST) number is indicated.JCB • VOLUME 182 • NUMBER 4 • 2008  662
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levels after control or SIK-speciﬁ  c knockdown in triplicate (  PAI-1  ,   p21  , and 
  p15  ) or quadruplicate (  Smad7  ) determinations. 
  Promoter-reporter assays 
  HepG2 cells transfected with the Smad3-responsive reporter pGL3-
CAGA  12  -luc for 36 h before stimulation with TGF-     1 for 6 h were analyzed 
with the enhanced luciferase assay kit (BD Biosciences). Normalized pro-
moter activity is plotted as mean values from triplicate determinations with 
standard deviations. 
  Immunoblotting, immunoprecipitation, and ubiquitination assays 
  SDS-PAGE, immunoblot, coimmunoprecipitation, pulldown, and ubiquitina-
tion analysis was as previously described (  Kowanetz et al., 2004  ;   Mor  é  n 
et al., 2005  ). For efﬁ  cient detection of endogenous SIK, HaCaT cells were 
pretreated with 50   μ  M MG132 (EMD) for 6 h at 37  °  C. For pulse-chase 
analysis, a 30 min pulse with  
35  S-methionine/cysteine was followed by a 
chase, as indicated in the Figures and as previously described (  Mor  é  n 
et al., 2005  ). Cells treated with proteasomal inhibitor, calpain inhibitor I 
(  N  -Acetyl-Leu-Leu-norleucinal, LLnL; Roche) or lysosomal inhibitor chloro-
quine (Sigma-Aldrich) were also analyzed. To measure association be-
tween SIK and ubiquitinated proteins, HEK293T cells were transfected with 
Flag-SIK in one plate and HA-ubiquitin in another and treated with protea-
somal inhibitors, MG132, or LLnL. Individual cell lysates were combined 
before immunoprecipitation. 
  Confocal microscopy 
  Approximately 70% conﬂ   uent transfected Mv1Lu monolayers were ana-
lyzed by immunoﬂ   uorescence 24 h after transfection as previously de-
scribed (  Kowanetz et al., 2004  ). Nuclei were counterstained with DAPI or 
propidium iodide. A confocal microscope (Axiovert 200 M; Carl Zeiss, 
Inc.) equipped with LSM 510 laser was used with the 63  ×  /0.75 NA objec-
tive lens (Carl Zeiss, Inc.) and photographing at ambient temperature in the 
presence of immersion oil. Images acquired with a charge-coupled device 
camera (C4742-95; Hamamatsu Photonics) and the acquisition software 
QED Camera Plug-in v.1.1.6 (QED Imaging Inc.) were reduced in memory 
content using Photoshop 6.0 (Adobe), without additional processing. 
  Receptor afﬁ  nity cross-linking 
  Mv1Lu cells incubated on ice with iodinated TGF-     1 were cross-linked, as 
previously described (  Moustakas et al., 1993  ), and shifted to 37  °  C, as in-
dicated in the ﬁ  gure, before SDS-PAGE and autoradiography. 
  Online supplemental material 
  Fig. S1 shows endogenous SIK protein levels in response to TGF     1 and the 
lack of effect of SIK expression on GFP or Smad7 levels. Fig. S2 shows in-
teraction of SIK with ubiquitinated proteins and interaction between SIK 
and ALK5 in presence of ubiquitin. Fig. S3 shows mRNA proﬁ  les of   Smad7  , 
  p21  ,   c-myc  , and   Id2   during a time course in response to TGF     1 in control 
cells or after SIK knockdown. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200804107/DC1. 
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